improve study update: safety and efficacy of venetoclax retreatment in r/r cll
Published 1 year ago • 122 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
1:51
the safety and efficacy of retreatment with venetoclax plus rituximab in r/r cll
-
3:17
transcend-cll-004 study update: safety and efficacy of liso-cel in r/r cll
-
0:58
improving the long-term safety of cll treatment
-
2:30
towards strategies to optimize outcomes in cll
-
0:56
fixed-duration treatment strategies for frontline and relapsed cll
-
1:31
frontline treatment for cll: the changing paradigm
-
1:03
late effect surveillance following allosct: the publication of new guidelines
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
1:36
selecting the best treatment option in cll
-
1:28
the future of cll treatment
-
1:33
key factors affecting treatment decision making in cll
-
4:38
venice i: venetoclax in r/r cll patients
-
2:31
improving patient outcomes and extending survival in cll
-
1:42
the future of cll treatment: aiming for long-lasting remission
-
2:41
btk and plcg2 mutations in cll patients taking ibrutinib
-
2:59
low-intensity venetoclax-based preconditioning followed by sequential allosct for r/r aml or hr-mds
-
3:07
barriers to progressing cll treatment in taiwan: treatment access and biomarkers
-
1:18
involving the patient in treatment decisions for cll
-
1:25
strategies to improve the efficacy of car-ts in cll